(August 27, 2018, 11:23 AM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on Aug. 23 denied exclusion of a plaintiff’s specific causation expert and granted partial summary judgment in a bellwether trial case, but kept several claims intact for a November trial (In Re: Testosterone Replacement Therapy Products Liability Litigation [Dominick Papandrea, et al. v. AbbVie, Inc., et al., No. 14-8948], No. 14-1748, N.D. Ill., Eastern Div., 2018 U.S. Dist. LEXIS 143367)....